NLC Health Ventures is an Amsterdam health-technology venture builder and early-stage investor founded in 2015. It finds inventions from universities, academic hospitals and corporations, forms companies around them, recruits entrepreneurial leaders and supports development, financing and commercialization. Its work spans therapeutics and biotechnology, cardiovascular and image-guided therapies, orthopedics, spine and surgery, and other healthcare technologies such as diagnostics and digital health. Its captive funds invest in selected NLC ventures and provide initial and follow-on capital from pre-seed through later development. The portfolio includes brain-monitoring and brain-computer-interface diagnostics, neurological therapeutics and AI-assisted medical diagnosis alongside other medical innovations. NLC combines healthcare, business and investment professionals with specialist advisers and venture CEOs rather than treating every member of its wider expert network as staff.
Founded
2015
Type
Venture capital
Funds1
NLC Health Impact Fund Coöperatief U.A.€36M
Fourth NLC captive healthcare venture fund, investing in a diversified portfolio of NLC-built companies across medtech, biotechnology and digital health in Europe and the United States, with initial and follow-on financing from pre-seed through Series A/B. The current manager page reports total size EUR36.5 million and a2026 close; exact month/day is undisclosed. The fund has actively invested since2023 and includes50+ companies. Legal fund name and Dutch jurisdiction are provided in the own manager teaser. Earlier EUR100m target, planned closing timetable and an archived34.4m extension-stage figure are separate disclosures for this same vehicle.
Crainio
Neurolieve Biosciences
MindAffect